Practitioners' Guide for Improving Oral Anticoagulant Use
Continuing Education Credit for this activity is no longer available.
About This Site:
This activity is supported by the U.S. Food and Drug Administration (FDA) through a contract from the U.S. Department of Health and Human Services. FDA's privacy policy applies while you are on this site.
Target Audience:
The target audience for this course is healthcare professionals, including physicians, physician assistants, nurses, nurse practitioners, pharmacists, and pharmacy technicians.
Description:
This online course will educate a national audience of healthcare providers about improving anticoagulant use.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Discuss the prevalence and types of adverse drug events related to oral anticoagulants.
- Review the drug classifications of oral anticoagulants.
- Compare characteristics of oral vitamin K antagonists and direct acting oral anticoagulants.
- Identify pathophysiological states for utilization of oral anticoagulation therapy.
- Review barriers to proper oral anticoagulant use.
- List steps that clinicians can take to reduce the risk of adverse drug events from oral anticoagulants.
Acknowledgement of Financial Commercial Support:
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support:
No in-kind commercial support was received for this educational activity.
Disclosure Information
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content of the course. All of these relationships were treated as a conflict of interest and have been resolved. (C7 SCS 6.1--6.2, 6.5).
All individuals in a position to control the content of the course are listed below and had no relevant financial relationship to disclose.
| First Name | Last Name | Disclosure |
|---|---|---|
| Fran | Cunningham | Nothing to disclose |
| Ellen | Eckes | Nothing to disclose |
| Elaine | Frost | Nothing to disclose |
| Mary | George | Nothing to disclose |
| Mary | Ghods | Nothing to disclose |
| Lisa | Longo | Nothing to disclose |
| Sophia | Ni | Nothing to disclose |
| Clydette | Powell | Nothing to disclose |
| Rachel | Shaw | Nothing to disclose |
| Anita | Thomas | Nothing to disclose |
| Victoria | Wilson | Nothing to disclose |
| Scott | Winiecki | Nothing to disclose |
| Joyce | Yu | Nothing to disclose |
Handouts and Resources:
Technical Requirements and Instructions:
To access the course, users will need a computer with an Internet connection, and:
- Internet Explorer 10 or higher,
- Firefox 43 or higher,
- Safari 9 or higher, or
- Any other W3C standards compliant browser
An HTML5 capable browser is required for video playback. Occasionally, other additional software may be required such as Microsoft PowerPoint or Adobe Acrobat Reader. Viewing on a desktop, laptop, or tablet is recommended.
This is a responsive course. Parts of the course may display differently across various devices and screen resolutions. Scrolling may be required in some instances.
For questions about content or about technical issues, you may contact FDA:
Toll Free
(855) 543-3784, or
(301) 796-3400
druginfo@fda.hhs.gov